Tagged Articles

neonatal abstinence syndrome 3 articles

Proposed class of babies born addicted to opioids targets drug companies

More than 20 drug companies were hit with a proposed class action brought by dozens of children who were born addicted to opioid painkillers, a condition known as Neonatal Abstinence Syndrome, or NAS. The latest attack in the fight to curb the opioid epidemic blames the pharmaceutical companies for ignoring regulations in order to increase their profits, which allowed the drugs into the black market, further fueling the nation’s opioid crisis. According to the 95-page complaint, the number of babies born addicted to opioids in the United States has jumped from 1.2 per 1,000 babies in 2000 to 5.8 per ... Read More

Babies born addicted to opioids won’t get separate track in MDL

Babies born addicted to opioids after being exposed to the drugs in their mothers’ wombs will not get a separate track in the multidistrict litigation (MDL) blaming opioid manufacturers, distributors and pharmacies of fueling the opioid epidemic, the Ohio federal judge overseeing the litigation ruled. Attorneys representing the so-called opioid babies argued in May that their clients deserved a special track in the MDL to address their special medical needs, such as long-term cognitive impairments. But U.S. District Judge Dan Aaron Polster denied the request. The complicated multidistrict litigation includes various local governments as well as Native American tribes, each ... Read More

Widely used SSRIs raise concerns of birth defects

According to a recent study, nearly 75 percent of all antidepressants were prescribed to patients without documented psychiatric conditions by non-psychiatrists in 2007, raising a host of concerns including the potential for patients to suffer serious side effects from the drugs that could put their unborn children at risk. The study, which was published in the Health Affairs journal, was co-authored by Mark Olfson, a professor of clinical psychiatry at Columbia University. The results were reported by the Wall Street Journal. Antidepressants were the second-most widely prescribed class of drugs in 2010, second only to cholesterol-lowering statins. Zoloft or a ... Read More